Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer
出版年份 2020 全文链接
标题
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer
作者
关键词
Flubendazole, Castration-resistant prostate cancer (CRPC), P53, Ferroptosis, Anti-tumor
出版物
PHARMACOLOGICAL RESEARCH
Volume 164, Issue -, Pages 105305
出版商
Elsevier BV
发表日期
2020-11-14
DOI
10.1016/j.phrs.2020.105305
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway
- (2020) Xumin Zhou et al. Frontiers in Pharmacology
- The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma
- (2019) Jiali Tao et al. OncoTargets and Therapy
- Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
- (2019) Shengling Fu et al. CANCER LETTERS
- Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
- (2019) Shichong Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ferroptosis is a lysosomal cell death process
- (2018) Huan Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer
- (2018) Yoon-Jae Kim et al. CANCER LETTERS
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium
- (2018) Haider H. Dar et al. JOURNAL OF CLINICAL INVESTIGATION
- The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells
- (2017) Veronika Hanušová et al. Anti-Cancer Agents in Medicinal Chemistry
- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
- (2016) Haitao Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Flubendazole induces mitotic catastrophe and senescence in colon cancer cellsin vitro
- (2016) Věra Králová et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Ferroptosis: Death by Lipid Peroxidation
- (2016) Wan Seok Yang et al. TRENDS IN CELL BIOLOGY
- Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
- (2015) Le Jiang et al. CELL CYCLE
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen
- (2015) Martin Michaelis et al. Scientific Reports
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep
- (2013) L. Ceballos et al. ACTA TROPICA
- Metabolic Regulation by p53 Family Members
- (2013) Celia R. Berkers et al. Cell Metabolism
- To be, or not to be
- (2013) Shang-Jui Wang et al. CURRENT OPINION IN ONCOLOGY
- The regulation of cellular metabolism by tumor suppressor p53
- (2013) Yingjian Liang et al. Cell and Bioscience
- p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
- (2013) Liz J. Valente et al. Cell Reports
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Performances of Flubendazole and Albendazole in Cystic Echinococcosis:Ex VivoActivity, Plasma/Cyst Disposition, and Efficacy in Infected Mice
- (2011) Laura Ceballos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
- (2011) Colleen A. Brady et al. CELL
- Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs
- (2011) Charles D Mackenzie et al. Expert Review of Anti-Infective Therapy
- Deconstructing p53 transcriptional networks in tumor suppression
- (2011) Kathryn T. Bieging et al. TRENDS IN CELL BIOLOGY
- The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
- (2010) P. A. Spagnuolo et al. BLOOD
- Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
- (2010) S. Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
- (2010) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Flubendazole in cystic echinococcosis therapy: Pharmaco-parasitological evaluation in mice
- (2009) Laura Ceballos et al. PARASITOLOGY INTERNATIONAL
- Androgen deprivation therapy for prostate cancer
- (2008) Eric A Singer et al. EXPERT OPINION ON PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search